Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jocelyn Mahoumbou"'
Autor:
Micheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, Jean Ronald Edoa, Guy Arnault Rogue Mfoumbi Ibinda, Bayodé Romeo Adegbite, Rhett Chester Mevyann, Christopher Mebiame Biyogho, Jocelyn Mahoumbou, Stredice Manguinga, Nina Mbenga Roguet, Bertrand Lell, Peter Gottfried Kremsner, Abraham Sunday Alabi, Martin Peter Grobusch, Ayola Akim Adegnika
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Non-tuberculous mycobacteria (NTM) are a group of bacteria that cause rare lung infections and are increasingly recognized as causative agents of opportunistic and device-associated infections in humans. In Gabon, there is a lack
Externí odkaz:
https://doaj.org/article/735d3571b1d543ad8e945b350a934974
Autor:
Abraham Sunday Alabi, Afsatou Ndama Traoré, Marguerite Massinga Loembe, Ulysse Ateba-Ngoa, Matthias Frank, Ayola Akim Adegnika, Bertrand Lell, Jocelyn Mahoumbou, Carsten Köhler, Peter Gottfried Kremsner, Martin Peter Grobusch
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 81-84 (2017)
Both routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Médicales de Lambaréné (CERMEL) took a strategic decision to expand its activities
Externí odkaz:
https://doaj.org/article/91b9d8d1eb484d0ea07681d3c73f0c4f
Autor:
Jabar Babatunde Pacome Achimi Agbo Abdul, Bayode Romeo Adegbite, Micheska Epola Dibamba Ndanga, Jean Ronald Edoa, Rhett Chester Mevyann, Guy Rogue Arnault Ibinda Mfoumbi, Tshisekedi Jean de Dieu, Jocelyn Mahoumbou, Christopher Mebiame Biyogho, Sankarganesh Jeyaraj, Stefan Niemann, Bertrand Lell, Peter Gottfried Kremsner, Abraham Sunday Alabi, Ayola Akim Adegnika, Martin Peter Grobusch
Publikováno v:
Infection. Urban und Vogel
Objective Routinely generated surveillance data are important for monitoring the effectiveness of MDR-TB control strategies. Incidence of rifampicin-resistant tuberculosis (RR-TB) is a key indicator for monitoring MDR-TB. Methods In a longitudinal na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8848726edd0b2c7eacbedb3bba57d137
https://pubmed.ncbi.nlm.nih.gov/36307576
https://pubmed.ncbi.nlm.nih.gov/36307576
Autor:
Ayola A. Adegnika, Afsatou Ndama Traore, Jocelyn Mahoumbou, Martin P. Grobusch, Carsten Köhler, Peter G. Kremsner, Bertrand Lell, Ulysse Ateba-Ngoa, Matthias Frank, Abraham Alabi, Marguerite Massinga Loembe
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 81-84 (2017)
International journal of infectious diseases : IJID, 56, 81-84. Elsevier
International journal of infectious diseases : IJID, 56, 81-84. Elsevier
Both routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Medicales de Lambarene (CERMEL) took a strategic decision to expand its activities by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d806dcbb0ca9b54bc7e92336f690937
http://www.sciencedirect.com/science/article/pii/S1201971216316228
http://www.sciencedirect.com/science/article/pii/S1201971216316228